Harvard Bioscience Assets & Liabilities Overview 2010-2023 | HBIO
Harvard Bioscience assets & liabilities overview from 2010 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
| Harvard Bioscience Annual Assets & Liabilities Overview (Millions of US $) |
|---|
| Harvard Bioscience Quarterly Assets & Liabilities Overview (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.167B | $0.112B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mettler-Toledo (MTD) | United States | $26.777B | 32.88 |
| Bruker (BRKR) | United States | $10.180B | 28.36 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 11.81 |